Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX With or Without Celecoxib in Resected Stage III Colon Cancer
NCT01150045Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2010
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of celecoxib oral solution in colon cancer (4 arms), sponsored by Cancer and Leukemia Group B. Primary endpoint: Disease-free Survival at 3 years. Started Jun 2010; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT01150045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01150045.